Technology | June 29, 2006

System Addresses Demand for Defibrillation Energy

Guidant Corp.’s VITALITY HE implantable cardioverter defibrillator combines the small, physiologic profile and exceptional longevity with the capacity to deliver more energy to defibrillate the patient. It also provides excellent diagnostics and fast charge times.
The VITALITY HE offers the advanced functionality of the VITALITY family. Recent usage data suggest that more than half of conventional defibrillators implanted in the U.S. today have higher energy output capability.

Related Content

The global, prospective, non-randomized UNTOUCHED study evaluated the safety and efficacy of the Boston Scientific Emblem S-ICD System – the only approved implantable defibrillator without wires touching the heart –  for primary prevention of sudden cardiac death specifically in patients with a left ventricular ejection fraction (LVEF) ≤35 percent, the most common population to be indicated for ICD therapy. #Heartrhythm2020 #HRS20 #HRS2020
News | Implantable Cardioverter Defibrillator (ICD) | May 08, 2020
May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) Sys
The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 08, 2020
May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable cardio
Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator
News | Implantable Cardioverter Defibrillator (ICD) | October 11, 2019
Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational Extravascular Implantable...
Early ICD Use Prolongs Survival After Coronary Stenting
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019
Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention lengthens survival in...
A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 24, 2019 | Dave Fornell, Editor
This is a brief overview of updates on...
Emblem Subcutaneous ICD Safe and Effective for Majority of Patients
News | Implantable Cardioverter Defibrillator (ICD) | May 13, 2019
May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of t
Medtronic Begins Pilot Study of Investigational Extravascular ICD System
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...